Oral Abstract Session 01 - Global HIV Vaccine Enterprise

Monday, 10 September
Program
13:30 – 14:45 Oral Abstract Session 04: BCEC Level 3,
Mucosal Immunity Room 258 ABC
Chairs: Daniel Douek and Jo-Ann Passmore
13:30 – 13:45 Immune Complexes Can Dampen Inflammatory Signaling at the OA04.01
Mucosal Surface During Protective SIV Vaccination
AJ Smith, SW Wietgrefe, CS Reilly, PJ Southern, L Duan, KE Perkey,
L Shang, R Johnson, AT Haase
13:45 – 14:00 Vaccine-elicited Systemic and Mucosal Humoral Responses of OA04.02
Lactating Rhesus Monkeys Vaccinated with the Transmitted/Founder
HIV Envelope 1086C
G Fouda, J Amos, AB Wilks, A Chand, D Montefiori, B Haynes, N Letvin,
D Pickup, H Liao, SR Permar
14:00 – 14:15 Expanded Memory CD4+ T Cells in the Fetal and the Infant Gut; OA04.03
a Mucosal Route for Mother-to-Child-Transmission of HIV-1
MJ Bunders, C van der Loos, PL Klarenbeek, J van Hamme, J Wilde,
N de Vries, RA van Lier, N Kootstra, ST Pals, TW Kuijpers
14:15 – 14:30 Cell Free HIV-1 Virus Can Infect Inner and Outer Foreskin OA04.04
Polarized Explants
MP Lemos, ML Perez, J Sanchez, J Lama, S Montano, J McElrath
14:30 – 14:45 Inflammation in the Male Genital Tract: Implications for HIV OA04.05
Acquisition and Transmission
AJ Olivier, L Roberts, D Coetzee, A Williamson, JS Passmore, WA Burgers
13:30 – 14:45 Oral Abstract Session 05: BCEC Level 2,
Social/Ethical Issues Room 253 ABC
Chairs: Barney Graham and Jonathan Fuchs
13:30 – 13:45 New Tools to Measure Community and Stakeholder Engagement OA05.01
and Its Impact on Outcomes of Clinical Research
P Bahati, S Hannah, S Seidel, S Aggett, R Siskind, R Campbell, S Williams,
A Downie, S Rosas
13:45 – 14:00 An Assessment of Good Participatory Practice Guidelines at HIV OA05.02
Prevention Research Clinical Centers in Eastern and Southern Africa
BP Ngongo, S Hannah, J Mbogua, M Seyoum, M Warren, E Baas, F Priddy
14:00 – 14:15 Social and Ethical Considerations in Engaging American Indian and OA05.03
Alaska Native Communities in HIV Clinical Research
J Velcoff, DL Humes, R Foley, M Ignacio
14:15 – 14:30 Knowledge/Attitude/Practices of HPV & Cervical Cancer, Willingness to Participate OA05.04
in Vaccine Trial in Preparation for HIV & HPV Vaccine Trials in Mali
D Poole, K Tracy, L Levitz, S Yekta, E Kossow, T Huang, M Rochas, K Sangare,
K Tounkara, B Aboubacar, O Koita, F Siby Diallo, S Sow, I Téguété, A Dolo,
F Bougoudogo, M Lurie, AS De Groot
14:30 – 14:45 Referral and Access to Care of HIV Prevalent Cases; Experience from OA05.05
the Early Capture HIV Cohort Study in Kampala
LN Mutengu, H Kibuuka, M Millard, A Sekiziyivu, S Wakabi, J Nanyondo,
G Kawooya, M Robb, N Michael
AIDS Vaccine 2012
5
PROGRAM / MONDAY